<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=9151474&amp;fmt=gif">
Skip to content

Compare

Odins vs ProclaimRx

ProclaimRx is a pharma commercial intelligence platform from Tiburon, California, and in October 2026 it launched a marketing mix modeling product for commercial-stage biopharma. Odins is a managed marketing mix model across industries. Here is what ProclaimRx brings, and where the two differ.

Reviewed October 2026 · sources cited on this page

At a glance

Side by side.

The short version of the whole page. Details and sources below.

Odins
ProclaimRx
What it is
OdinsA managed marketing investment platform: data, model, recommendations and a team behind them
ProclaimRxA pharma commercial data and AI platform, with an MMM product launched in October 2026
Segment
OdinsAdvertisers across industries, from EUR 1M to several hundred million a year in marketing budget
ProclaimRxCommercial-stage biopharma: commercial, marketing, sales and medical affairs teams
Methodology
OdinsBayesian MMM, one model per market, priors set with your team in 2 to 3 working sessions
ProclaimRxPowered by PLAiTO, a pharma-trained AI engine; every recommendation traceable to data and assumptions, per their release; statistical method not stated publicly
Data
OdinsSpend, sales and business drivers; we collect and structure them for you
ProclaimRxPharma data such as HCP profiles, field data, CRM, Rx, access, patient hub, digital media and market research
Cadence
OdinsDaily data flow, monthly retrain and reviewed recommendation; scenarios and forecasts any time
ProclaimRxOn-demand models on current data, positioned against the annual MMM exercise
Service model
OdinsFully managed: data integration, model build and maintenance, and a person reviews every recommendation
ProclaimRxA co-sourced model built around each client's business rules, per an advisor quoted in the launch release
Interface
OdinsPlatform, or questions to the model from Claude via the Odins MCP
ProclaimRxPLAiTO, an embedded assistant that answers business questions in plain English
Cost
OdinsSubscription priced for the budget it optimizes
ProclaimRxNot published; demo on request
Time to value
OdinsFirst verified model in 4 to 6 weeks from kickoff, data collection and structuring included
ProclaimRxAnalyses in hours once running, per their release; onboarding time not stated publicly

ProclaimRx facts: proclaimrx.com home, capabilities, functions and about pages, and the ProclaimRx MMM launch release of 26 October 2026, read October 2026. ProclaimRx does not state its statistical method, pricing or onboarding time publicly.

The honest read

Credit first: ProclaimRx speaks pharma's language.

Pharma marketing runs on data a general MMM vendor rarely sees: HCP targeting, field force activity, Rx and access. ProclaimRx was built for those teams by people from the industry, and its MMM sits on that data.

  • Built for commercial-stage biopharma, with the HCP, field, Rx and access data that market runs on
  • On-demand models on current data, in place of a once-a-year MMM study
  • A stated commitment to traceability: recommendations tied back to data and business assumptions
  • A plain-language assistant, PLAiTO, for brand and commercial teams
The difference

Built for different questions: pharma commercial data, or the media budget.

ProclaimRx is a commercial data platform for pharma that now includes MMM. Odins is a marketing mix model first, run for advertisers across industries: one Bayesian model per market, priors set with your team, and a forecast record you can inspect.

  • One Bayesian model per market for budget size and allocation, with confidence ranges
  • TV, radio, OOH and print in the same model as digital, next to pricing and promotions
  • Forecasts stored before actuals arrive and checked at each monthly retrain, while data flows in daily and scenarios run any time
  • Fully managed, with a person reviewing every recommendation and the model open to questions from Claude via the Odins MCP

Channel contribution, 80% ranges

from the posterior
Search 14 to 16% optimize
Social 9 to 13% optimize
Display 2 to 9% test first

A tight range is a decision. A wide range is a test plan, with cost boundaries.

The choice

Who should choose which.

This choice is mostly about your industry and your data.

Choose ProclaimRx if

  • You are a commercial-stage biopharma brand and the decision runs on HCP, field force, Rx and access data
  • You want MMM inside a wider pharma commercial intelligence platform
  • Your brand, sales and medical affairs teams want one assistant across all of that data

Choose Odins if

  • You advertise to consumers or businesses, with a marketing budget from EUR 1M to several hundred million a year
  • TV, radio, OOH or print carry real budget, next to digital and pricing and promotions
  • You want the model run for you, with a person reviewing every recommendation and forecasts checked against actuals

The honest overlap

The overlap is narrow. Both promise scenarios on current data in place of a yearly study. ProclaimRx is built around pharma's commercial data; Odins around the media budget across industries. Ask either vendor to show the model behind one recommendation.

FAQ

Frequently asked questions.

Is ProclaimRx a marketing mix model?

ProclaimRx is a pharma commercial intelligence platform. In October 2026 it launched an MMM product for commercial-stage biopharma, powered by its PLAiTO AI engine, with budget scenario simulation and on-demand models. It does not state its statistical method publicly. Odins is a Bayesian marketing mix model, run for you.

Who is ProclaimRx for?

Commercial-stage biopharma: marketing, sales, commercial and medical affairs teams. Its platform works with pharma data such as HCP profiles, field data, CRM, Rx, access and market research.

How much does ProclaimRx cost?

ProclaimRx does not publish pricing; it offers demos on request. We do not publish a price list either. Odins is a subscription priced for the budget it optimizes, for companies with a marketing budget from EUR 1M to several hundred million a year, with the team included and no data science hires needed.

Can Odins model pharma or healthcare marketing?

Odins models any business where marketing spend drives a sales series, with business drivers next to media. A brand whose decision rests on HCP targeting, field force and Rx data is better served by a pharma specialist such as ProclaimRx. Where the question is the size and split of the media budget, Odins fits.

ProclaimRx runs analyses in hours. How fast is Odins?

Once the model is live, scenarios and forecasts run any time, in the platform or from Claude via the Odins MCP. A first verified model takes 4 to 6 weeks from kickoff, data collection and structuring included. Vendors who quote shorter timelines usually count from the day your data is already collected and prepared, and often do not offer data collection at all.

What are the best alternatives to ProclaimRx?

It depends on what you need from the model. We compared five options, with sources and who each one fits, on a separate page: the best ProclaimRx alternatives. Odins is on the list, and we say so up front.

Talk to our team

Marketing spend, modeled like an investment.

A 30-minute walkthrough of the model, the priors and the verification, on your channels.

Book a demo